Growth factors as drugs for neurological and sensory disorders

LDR 01680nam a2200397 a 4500
001 003088793
003 MiAaHDL
005 20210817000000.0
006 m d
007 cr bn ---auaua
008 961009s1996 enka b 101 0 eng c
010 ⊔ ⊔ ‡a95048131
020 ⊔ ⊔ ‡a0471957216 ‡q(alk. paper)
035 ⊔ ⊔ ‡a(MiU)990030887930106381
035 ⊔ ⊔ ‡asdr-miu.990030887930106381
035 ⊔ ⊔ ‡a(OCoLC)33949138
035 ⊔ ⊔ ‡z(MiU)Aleph003088793
040 ⊔ ⊔ ‡aDNLM/DLC ‡cDLC ‡dNLM ‡dIAI ‡dNOH ‡dC#P ‡dEYM
050 0 0 ‡aRC394.D35 ‡bG76 1996
060 1 0 ‡aWL 300 ‡bG8845 1996
060 1 0 ‡aW3 ‡bC161F v.196 1996
082 0 0 ‡a616.8/0461 ‡220
245 0 0 ‡aGrowth factors as drugs for neurological and sensory disorders / ‡c[editors, Gregory R. Bock (organizer) and Jamie A. Goode].
260 ⊔ ⊔ ‡aChichester ; ‡aNew York : ‡bJ. Wiley & Sons, ‡c1996.
300 ⊔ ⊔ ‡aix, 253 p. : ‡bill. ; ‡c24 cm.
490 0 ⊔ ‡aCiba Foundation symposium ; ‡v196
500 ⊔ ⊔ ‡aPapers presented at a symposium held at the Ciba Foundation, London, 25-27 April 1995.
504 ⊔ ⊔ ‡aIncludes bibliographical references and indexes.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 2 ‡aPeripheral Nervous System Diseases ‡xdrug therapy ‡xcongresses.
650 ⊔ 2 ‡aNeuromuscular Diseases ‡xdrug therapy ‡xcongresses.
650 ⊔ 2 ‡aCentral Nervous System Diseases ‡xdrug therapy ‡xcongresses.
650 ⊔ 2 ‡aGrowth Substances ‡xtherapeutic use ‡xcongresses.
650 ⊔ 0 ‡aAfferent pathways ‡xDiseases ‡xChemotherapy ‡xCongresses.
650 ⊔ 0 ‡aGrowth factors ‡xTherapeutic use ‡xCongresses.
650 ⊔ 0 ‡aNeuropharmacology
650 ⊔ 0 ‡aNerve growth factor ‡xTherapeutic use ‡xCongresses.
650 ⊔ 0 ‡aNervous system ‡xDegeneration ‡xChemotherapy ‡xCongresses.
700 1 ⊔ ‡aGoode, Jamie.
700 1 ⊔ ‡aBock, Gregory.
CID ⊔ ⊔ ‡a003088793
DAT 0 ⊔ ‡a19970205000000.0 ‡b20210817000000.0
DAT 1 ⊔ ‡a20210923060709.0 ‡b2023-08-08T17:44:49Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990030887930106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015037822106 ‡sMIU ‡1990030887930106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20230808 ‡sgoogle ‡umdp.39015037822106 ‡y1996 ‡ric ‡qbib ‡tnon-US bib date1 >= 1929